2010
DOI: 10.1007/s00540-010-1030-2
|View full text |Cite
|
Sign up to set email alerts
|

Suppressive effects of sivelestat on interleukin 8 and TNF-α production from LPS-stimulated granulocytes in whole blood culture

Abstract: Suppression of granulocytic production of IL-8 and TNF-α by sivelestat suggests that this drug may be useful for treatment of morbid conditions involving IL-8 and TNF-α at onset.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 20 publications
1
9
0
Order By: Relevance
“…As neutrophils express Toll-like receptor (TLR)4 [15, 16], the receptor for LPS [16], and produce a variety of inflammatory mediators including chemoattractants for eosinophils, such as leukotriene (LT)B 4 and platelet-activating factor (PAF), on LPS stimulation [1719], we hypothesised that LPS-stimulated neutrophils would play some role in the pathogenesis of eosinophilic inflammation observed with some cases of severe asthma, especially in neutrophil-dependent eosinophil accumulation in the airway. In the present study, we examined whether neutrophils stimulated with LPS modify the TBM of eosinophils.…”
Section: Introductionmentioning
confidence: 99%
“…As neutrophils express Toll-like receptor (TLR)4 [15, 16], the receptor for LPS [16], and produce a variety of inflammatory mediators including chemoattractants for eosinophils, such as leukotriene (LT)B 4 and platelet-activating factor (PAF), on LPS stimulation [1719], we hypothesised that LPS-stimulated neutrophils would play some role in the pathogenesis of eosinophilic inflammation observed with some cases of severe asthma, especially in neutrophil-dependent eosinophil accumulation in the airway. In the present study, we examined whether neutrophils stimulated with LPS modify the TBM of eosinophils.…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, enzyme inhibition experiments revealed that NE must be catalytically active to induce mRNA expression of TNF-␣, MIP-2, and IL-6. In support of this observation, sivelestat, a selective synthetic neutrophil elastase inhibitor, has been reported to suppress the production of TNF-␣ and MIP-2 by LPS and/or NE-stimulated leukocytes in whole blood culture (27,28). We have purposely used the synthetic inhibitor AEBSF instead of physiologic inhibitors such as SLPI because these latter have been reported to down-regulate the expression of inflammatory mediators (29,30).…”
Section: Discussionmentioning
confidence: 88%
“…1), a specific low-weight HNEI, has been approved in Japan for the treatment of ALI/ARDS with systemic inflammatory response syndrome (SIRS) [8]. ONO-5046 is not sensitive to active oxygen radicals and effectively penetrates to the lesion location to improve pulmonary function in patients through attenuating the influx and stiffness of neutrophils and the permeability of pulmonary vessels [9,10]; reducing the levels of some inflammatory mediators, such as NO, interleukin 6, interleukin 8, and TNF-␣, among others [11][12][13]. However, ONO-5046 does not improve the mortality outcome of ALI/ARDS patients [14].…”
Section: Introductionmentioning
confidence: 99%